Maximus, Inc. (MMS) Director Russell A. Beliveau Sells 1,500 Shares

Maximus, Inc. (NYSE:MMS) Director Russell A. Beliveau sold 1,500 shares of the company’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $64.30, for a total value of $96,450.00. Following the completion of the sale, the director now owns 40,329 shares in the company, valued at approximately $2,593,154.70. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Maximus, Inc. (NYSE:MMS) opened at $69.18 on Monday. The stock has a market capitalization of $4,506.15, a price-to-earnings ratio of 22.24, a PEG ratio of 2.60 and a beta of 1.35. Maximus, Inc. has a 52 week low of $51.74 and a 52 week high of $69.20.

The company also recently declared a quarterly dividend, which was paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th were paid a $0.045 dividend. The ex-dividend date of this dividend was Tuesday, November 14th. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.26%. Maximus’s dividend payout ratio (DPR) is currently 5.66%.

Several hedge funds have recently added to or reduced their stakes in MMS. Teachers Advisors LLC raised its holdings in Maximus by 5.9% in the 1st quarter. Teachers Advisors LLC now owns 119,967 shares of the health services provider’s stock worth $7,462,000 after purchasing an additional 6,696 shares during the period. Dimensional Fund Advisors LP raised its holdings in Maximus by 3.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 632,118 shares of the health services provider’s stock worth $39,318,000 after purchasing an additional 19,788 shares during the period. AQR Capital Management LLC raised its holdings in Maximus by 0.9% in the 1st quarter. AQR Capital Management LLC now owns 40,868 shares of the health services provider’s stock worth $2,542,000 after purchasing an additional 361 shares during the period. Fox Run Management L.L.C. bought a new position in Maximus in the 2nd quarter worth $326,000. Finally, Capstone Asset Management Co. raised its holdings in Maximus by 1.1% in the 2nd quarter. Capstone Asset Management Co. now owns 7,052 shares of the health services provider’s stock worth $442,000 after purchasing an additional 80 shares during the period. Hedge funds and other institutional investors own 94.82% of the company’s stock.

Several analysts have commented on the company. Zacks Investment Research upgraded Maximus from a “hold” rating to a “buy” rating and set a $73.00 target price on the stock in a research note on Wednesday, October 4th. Robert W. Baird assumed coverage on Maximus in a research note on Sunday, September 3rd. They set a “neutral” rating on the stock. Finally, Canaccord Genuity cut their target price on Maximus from $62.00 to $61.00 and set a “hold” rating on the stock in a research note on Friday, November 10th. Two analysts have rated the stock with a sell rating and six have given a hold rating to the company’s stock. Maximus has an average rating of “Hold” and an average price target of $64.33.

COPYRIGHT VIOLATION WARNING: This piece was first published by Week Herald and is the sole property of of Week Herald. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://weekherald.com/2017/12/04/maximus-inc-mms-director-russell-a-beliveau-sells-1500-shares.html.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply